[Coagulation changes following injection of a purified contact activation product].
D000818:Animals; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D001792:Blood Platelets; D004211:Disseminated Intravascular Coagulation / Q000209:etiology*; D004731:Endotoxins; D005165:Factor V / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005172:Factor XI; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D008297:Male; D011817:Rabbits; D012485:Salmonella typhi; D013916:Thrombelastography; D013927:Thrombosis / Q000209:etiology
D004731:Endotoxins; D005165:Factor V; D005169:Factor VIII; D005340:Fibrinogen; D005172:Factor XI
Gerinnungsveräunderungen nach Injektion von gereinigtem Kontaktaktivierungsprodukt.